1,215
Participants
Start Date
January 1, 2015
Primary Completion Date
May 1, 2015
Study Completion Date
May 28, 2015
Spirometry
Classification of respiratory diseases by Spirometry will be performed to differentiate subjects between Asthma only, ACOS, and COPD only. Spirometry obtained from measurements in the past 6 months is acceptable for purposes of this study. For subjects without spirometry in the past 6 months, spirometry will be performed to obtain pre- and post-bronchodilator Forced Expiratory Volume in one second (FEV1), Forced Vital Capacity (FVC) and reversibility
ACOS clinical questionnaire
The 41-question questionnaire includes questions concerning the following: a) response to bronchodilator, b) disease progression, c) variations in symptom, d) atopic history, e) symptom triggers, f) vagal bias, g) burden of disease, h) symptom presentation, i) emotional aspects, and j) age of onset. In addition, two questions will capture patient perception of his/her respiratory disease and the physician's diagnosis
GSK Investigational Site, Kyiv
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Mendoza
GSK Investigational Site, San Rafael
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Morgantown
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Gaffney
GSK Investigational Site, Union
GSK Investigational Site, Greenville
GSK Investigational Site, Rock Hill
GSK Investigational Site, Hanover
GSK Investigational Site, Cincinnati
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Kharkiv
GSK Investigational Site, Kharkiv
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Sunset
GSK Investigational Site, Upland
GSK Investigational Site, Newport Beach
GSK Investigational Site, Medford
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saratov
GSK Investigational Site, Nizhny Novgorod
GSK Investigational Site, Blagoveshchensk
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Rosario
GSK Investigational Site, Buenos Aires
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Leipzg
GSK Investigational Site, Teuchern
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY